{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T01:00:57Z","timestamp":1791939657583,"version":"4.3.4"},"reference-count":42,"publisher":"The Endocrine Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,1,1]]},"DOI":"10.1210\/jc.2007-1834","type":"journal-article","created":{"date-parts":[[2007,10,9]],"date-time":"2007-10-09T20:44:53Z","timestamp":1191962693000},"page":"162-168","source":"Crossref","is-referenced-by-count":299,"title":["Impact of Obesity on the Risk for Polycystic Ovary Syndrome"],"prefix":"10.1210","volume":"93","author":[{"given":"Bulent O.","family":"Yildiz","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Endocrinology, and Metabolism Unit (B.O.Y.), Hacettepe University School of Medicine, Hacettepe, 06100 Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric S.","family":"Knochenhauer","sequence":"additional","affiliation":[{"name":"Department of Obstetrics\/Gynecology (E.S.K.), Staten Island University Hospital, Staten Island, New York 10305"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Azziz","sequence":"additional","affiliation":[{"name":"Cedars-Sinai Medical Center, and Departments of Obstetrics\/Gynecology and Medicine (R.A.), David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California 90048"},{"name":"Department of Obstetrics\/Gynecology and Center for Androgen Related Disorders (R.A.), David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California 90048"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"key\n\t\t\t\t2019041114023011500_R1","first-page":"3078","article-title":"Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study.","volume":"83","author":"Knochenhauer","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114023011500_R2","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1210\/jcem.84.11.6148","article-title":"A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile.","volume":"84","author":"Diamanti-Kandarakis","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114023011500_R3","first-page":"2434","article-title":"A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain.","volume":"85","author":"Asuncion","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114023011500_R4","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2003-032046","article-title":"The prevalence and features of the polycystic ovary syndrome in an unselected population.","volume":"89","author":"Azziz","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114023011500_R5","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3109\/09513598709023610","article-title":"Epidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studies.","volume":"1","author":"Hull","year":"1987","journal-title":"Gynecol Endocrinol"},{"key":"key\n\t\t\t\t2019041114023011500_R6","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/S0015-0282(02)03111-4","article-title":"Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus.","volume":"77","author":"Ovalle","year":"2002","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t2019041114023011500_R7","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1210\/er.2003-0004","article-title":"Polycystic ovary syndrome and cardiovascular disease: a premature association?","volume":"24","author":"Legro","year":"2003","journal-title":"Endocr Rev"},{"key":"key\n\t\t\t\t2019041114023011500_R8","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1016\/S0140-6736(03)13409-5","article-title":"Polycystic ovary syndrome and endometrial carcinoma.","volume":"361","author":"Hardiman","year":"2003","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019041114023011500_R9","doi-asserted-by":"crossref","first-page":"4650","DOI":"10.1210\/jc.2005-0628","article-title":"Healthcare-related economic burden of the polycystic ovary syndrome (PCOS) during the reproductive lifespan.","volume":"90","author":"Azziz","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114023011500_R10","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1385\/ENDO:29:1:109","article-title":"Epidemiology, trends, and morbidities of obesity and the metabolic syndrome.","volume":"29","author":"Bray","year":"2006","journal-title":"Endocrine"},{"key":"key\n\t\t\t\t2019041114023011500_R11","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/epirev\/mxm007","article-title":"The obesity epidemic in the United States\u2014gender, age, socioeconomic, racial\/ethnic, and geographic characteristics: a systematic review and meta-regression analysis.","volume":"29","author":"Wang","year":"2007","journal-title":"Epidemiol Rev"},{"key":"key\n\t\t\t\t2019041114023011500_R12","year":"2000"},{"key":"key\n\t\t\t\t2019041114023011500_R13","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.fertnstert.2005.10.054","article-title":"Obesity and androgens: facts and perspectives.","volume":"85","author":"Pasquali","year":"2006","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t2019041114023011500_R14","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.bpobgyn.2004.05.005","article-title":"Long-term metabolic, cardiovascular and neoplastic risks with polycystic ovary syndrome.","volume":"18","author":"Cattrall","year":"2004","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"key\n\t\t\t\t2019041114023011500_R15","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1093\/oxfordjournals.humrep.a135772","article-title":"Weight loss results in significant improvement in pregnancy and ovulation rates in anovulatory obese women.","volume":"10","author":"Clark","year":"1995","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t2019041114023011500_R16","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1093\/humrep\/13.6.1502","article-title":"Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment.","volume":"13","author":"Clark","year":"1998","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t2019041114023011500_R17","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1001\/archinte.166.19.2081","article-title":"Prevalence and characteristics of the polycystic ovary syndrome in overweight and obese women.","volume":"166","author":"Alvarez-Blasco","year":"2006","journal-title":"Arch Intern Med"},{"key":"key\n\t\t\t\t2019041114023011500_R18","first-page":"377","article-title":"Diagnostic criteria for polycystic ovary syndrome","author":"Zawadzki","year":"1992","journal-title":"In: Dunaif A, Givens J, Haseltine F, Merriam GR, eds. Polycystic ovary syndrome. Boston: Blackwell Scientific Publications;"},{"key":"key\n\t\t\t\t2019041114023011500_R19","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0015-0282(99)00383-0","article-title":"Screening for 21-hydroxylase-deficient nonclassic adrenal hyperplasia among hyperandrogenic women: a prospective study.","volume":"72","author":"Azziz","year":"1999","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t2019041114023011500_R20","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1210\/jc.2003-031122","article-title":"Androgen excess in women: experience with over 1000 consecutive patients.","volume":"89","author":"Azziz","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114023011500_R21","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S0015-0282(97)00464-0","article-title":"Measurement of total serum testosterone levels using commercially available kits: high degree of between-kit variability.","volume":"69","author":"Boots","year":"1998","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t2019041114023011500_R22","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/0002-9378(95)91488-9","article-title":"Chronic hyperinsulinemia and the adrenal androgen response to acute corticotropin-(1\u201324) stimulation in hyperandrogenic women.","volume":"172","author":"Azziz","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"key\n\t\t\t\t2019041114023011500_R23","first-page":"400","article-title":"Adrenal androgen excess in women: lack of a role for 17-hydroxylase and 17,20-lyase dysregulation.","volume":"80","author":"Azziz","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114023011500_R24","first-page":"1985","author":"Centers for Disease Control and Prevention","year":"2005"},{"key":"key\n\t\t\t\t2019041114023011500_R25","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1093\/oxfordjournals.humrep.a136243","article-title":"Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients.","volume":"10","author":"Balen","year":"1995","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t2019041114023011500_R26","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1093\/humrep\/deh214","article-title":"Prevalence of polycystic ovaries in women with self-reported symptoms of oligomenorrhoea and\/or hirsutism: Northern Finland Birth Cohort 1966 Study.","volume":"19","author":"Taponen","year":"2004","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t2019041114023011500_R27","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1055\/s-2005-870236","article-title":"Clinical and biochemical characterization of women with polycystic ovary syndrome in North Rhine-Westphalia.","volume":"37","author":"Hahn","year":"2005","journal-title":"Horm Metab Res"},{"key":"key\n\t\t\t\t2019041114023011500_R28","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1210\/jc.2004-2279","article-title":"Phenotypic variation in hyperandrogenic women influences the findings of abnormal metabolic and cardiovascular risk parameters.","volume":"90","author":"Carmina","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114023011500_R29","first-page":"1626","article-title":"Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial.","volume":"86","author":"Azziz","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114023011500_R30","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.fertnstert.2006.03.037","article-title":"The Pregnancy in Polycystic Ovary Syndrome study: baseline characteristics of the randomized cohort including racial effects.","volume":"86","author":"Legro","year":"2006","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t2019041114023011500_R31","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1046\/j.1365-2265.1999.00886.x","article-title":"Polycystic ovaries and associated clinical and biochemical features in young women.","volume":"51","author":"Michelmore","year":"1999","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041114023011500_R32","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1111\/j.1471-0528.2006.01008.x","article-title":"PCOS according to the Rotterdam consensus criteria: change in prevalence among WHO-II anovulation and association with metabolic factors.","volume":"113","author":"Broekmans","year":"2006","journal-title":"BJOG"},{"key":"key\n\t\t\t\t2019041114023011500_R33","first-page":"165","article-title":"Elevated serum TNF-\u03b1 levels in normal-weight women with polycystic ovaries or the polycystic ovary syndrome.","volume":"48","author":"Sayin","year":"2003","journal-title":"J Reprod Med"},{"key":"key\n\t\t\t\t2019041114023011500_R34","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/humrep\/deh010","article-title":"Serum and adipocyte resistin in polycystic ovary syndrome with insulin resistance.","volume":"19","author":"Seow","year":"2004","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t2019041114023011500_R35","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1093\/humrep\/del146","article-title":"Adiponectin and resistin in PCOS: a clinical, biochemical and molecular genetic study.","volume":"21","author":"Escobar-Morreale","year":"2006","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t2019041114023011500_R36","first-page":"e351","article-title":"Endothelial dysfunction in PCOS: role of obesity and adipose hormones","author":"Carmina","year":"2006","journal-title":"Am J Med 119:356"},{"key":"key\n\t\t\t\t2019041114023011500_R37","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/j.fertnstert.2005.10.038","article-title":"Serum soluble leptin receptor levels and free leptin index in women with polycystic ovary syndrome: relationship to insulin resistance and androgens.","volume":"85","author":"Sepilian","year":"2006","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t2019041114023011500_R38","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1530\/eje.1.02078","article-title":"Decreased soluble leptin receptor levels in women with polycystic ovary syndrome.","volume":"154","author":"Hahn","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t2019041114023011500_R39","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.metabol.2006.04.002","article-title":"Plasma interleukin 6 levels are elevated in polycystic ovary syndrome independently of obesity or sleep apnea.","volume":"55","author":"Vgontzas","year":"2006","journal-title":"Metabolism"},{"key":"key\n\t\t\t\t2019041114023011500_R40","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S1472-6483(10)61177-7","article-title":"Genetic and environmental origins of obesity relevant to reproduction.","volume":"12","author":"Franks","year":"2006","journal-title":"Reprod Biomed Online"},{"key":"key\n\t\t\t\t2019041114023011500_R41","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1365-2265.2006.02587.x","article-title":"Obesity and polycystic ovary syndrome.","volume":"65","author":"Barber","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041114023011500_R42","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1385\/ENDO:30:1:35","article-title":"Lifestyle choices, diet, and insulin sensitizers in polycystic ovary syndrome.","volume":"30","author":"Norman","year":"2006","journal-title":"Endocrine"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/93\/1\/162\/9053261\/jcem0162.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,3]],"date-time":"2019-05-03T13:37:49Z","timestamp":1556890669000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/93\/1\/162\/2598402"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1,1]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2007-1834","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1,1]]}}}